EGS Healthcare Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

EGS Healthcare Capital Partners’ most common sectors for investment aremedical products (58%) and life science (43%) . The Firm’s most common investment types include venture (72%) and buyout (lbo, mbo, mbi) (15%). In total, EGS Healthcare Capital Partners has invested in 4 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2003 when it acquired Ardais for $34M.

The Firm’s most common exit type is trade sale (43%). EGS Healthcare Capital Partners’ largest (disclosed) exit occurred in 2007 when it sold Cerexa for $480M.

Join Mergr to view EGS Healthcare Capital Partners’ full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity14
    • M&A Buy Activity7
    • M&A Sell Activity7
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 13

EGS Healthcare Capital Partners

EGS Healthcare Capital Partners LLC

105 Rowayton Avenue, 2nd Floor,
Rowayton, Connecticut 06853
United States
(203) 854-0559
www.egshealthcare.com
mderby@egshealthcare.com

EGS Healthcare Capital Partners is a specialist private equity firm focused on investments in the healthcare sector. Specific areas of interest include biotechnology, specialty pharmaceutical, and medical device companies. EGS typically invests in late-stage private and emerging public companies with promising products. EGS prefers to lead investments with an initial commitment of $5 million per transaction. The Firm generally seeks board representation. EGS Healthcare Partner was formed in 1999 and is based in Rowayton, Connecticut.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 3 7
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 7 - - - - - 7
vol $52M $52M
Sell (0.0/yr) # 7 - - - - - 7
vol $805M $805M
  14

Most Recent M&A

Company Date Value Type
Anesiva, Inc. 2010-01-15 - Bankruptcy
South San Francisco, California · www.anesiva.com
Jazz Pharmaceuticals PLC 2007-06-01 - IPO
Dublin, Ireland · www.jazzpharma.com
Endius, Inc. 2007-04-20 80M USD Trade Sale
Plainville, Massachusetts · www.endius.com
Cerexa, Inc. 2007-01-01 480M USD Trade Sale
Oakland, California · www.cerexa.com
Peninsula Pharmaceuticals, Inc. 2005-06-30 245M USD Trade Sale
Alameda, California · www.peninsulapharm.com
EKOS Corp. 2005-02-18 - Buyout (LBO, MBO, MBI)
Bothell, Washington · www.ekoscorp.com
Transport Pharmaceuticals, Inc. 2004-10-01 - Venture
Framingham, Massachusetts · www.transportpharma.com
Stereotaxis, Inc. 2004-08-12 - IPO
St. Louis, Missouri · www.stereotaxis.com
Jazz Pharmaceuticals PLC 2004-03-24 - Venture
Dublin, Ireland · www.jazzpharma.com
Anesiva, Inc. 2004-02-01 - PIPE
South San Francisco, California · www.anesiva.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products - - 4 (57%) 18M (35%)
Life Science - - 3 (43%) 34M (65%)
Total - - 7 $52M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States - - 6 (86%) 52M (100%)
  Massachusetts - - 3 (43%) 34M (65%)
  Missouri - - 1 (14%) 18M (35%)
  Washington - - 1 (14%) -
  California - - 1 (14%) -
Ireland - - 1 (14%) -
Domestic - - 6 (86%) 52M (100%)
Cross-border - - 1 (14%) -
Total - - 7 $52M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture - - 5 (71%) 52M (100%)
Buyout (LBO, MBO, MBI) - - 1 (14%) -
PIPE - - 1 (14%) -
Total - - 7 $52M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 3 (43%) 805M (100%)
IPO 2 (29%) -
Bankruptcy 1 (14%) -
Trade Sale 1 (14%) -
Total 7 $805M

Deal Values

buy # Total
< $100M 2 $52M
TOTAL $52M
Largest Ardais Corp.
$34M (2003-03-19)
sell # Total
$100M to $1B 2 $725M
< $100M 1 $80M
TOTAL $805M
Largest Cerexa, Inc.
$480M (2007-01-01)

M&A Connections

Deals
Exited to
Strategic(s)
43%
3 (43%)

Investor Summary

Investor Type

Private Equity Firm

Size

Small

PE Assets

135M USD

Established

1999

Specialist/Generalist

Specialist

FAQ

When was EGS Healthcare Capital Partners founded?

EGS Healthcare Capital Partners was founded in 1999.

What type of investor is EGS Healthcare Capital Partners?

EGS Healthcare Capital Partners is a private equity firm.

Where is EGS Healthcare Capital Partners headquartered?

EGS Healthcare Capital Partners is headquartered in Rowayton, Connecticut.

How much capital does EGS Healthcare Capital Partners have under management?

EGS Healthcare Capital Partners has 135M USD under management.

 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal